Allogene IPO shares rally in the midst of a market storm; The flip side? Hoth files for $13M IPO
→ The market overall may be in turmoil, but why should that bother the record-setting biotech IPO from Arie Belldegrun and David Chang. Allogene stock …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
